Due to COVID-19, new enrollment in research studies will be greatly limited.
If you are interested in a study, there may be a longer waiting period to receive a response to your inquiry.
View the guidance for research participants for additional information.
This study enrolls newborn infants with treatable retinopathy of prematurity (ROP). ROP is is one of the leading causes of childhood blindness worldwide. The purpose of this study is to learn if aflibercept (Eyelea) works to treat this condition. Read More
Children (newborn infants).
Gestational age at birth must be 32 weeks or less, birth weight must be 1500g or less
Must have retinopathy of prematurity (ROP) that has not yet been treated.
Must weigh at least 800 g
This study enrolls children ages 4-13 who have amblyopia ("lazy eye"). The purpose of the study is to learn if vision is improved by playing a binocular game while wearing corrective glasses. Read More
Children ages 4-13.
Diagnosed with amblyopia, also known as "lazy eye."
This study enrolls adults with Glaucoma who are scheduled for surgery. The purpose of this study is to learn the effects of varying the dose of the laser in a certain glaucoma surgical procedure (called MicroPulse Trans-Scleral CycloPhotoCoagulation). Read More
-Adults ages 18+ who have been diagnosed with Glaucoma.
-People who have been invited to participate because they have been scheduled for MicroPulse Trans-Scleral CycloPhotoCoagulation (MP-TSCPC) surgery
This study enrolls children with myopia, or nearsightedness. The purpose of this study is to learn whether the use of SYD-101, an eye solution, slows down the progression of myopia in children. Read More
-Children ages 3-14.
-Child must be in general good health.
-Must be diagnosed with myopia (nearsightedness) in both eyes.
The purpose of this study is to understand the relationship between three eye diseases (Agerelated macular degeneration, Fuchs’ endothelial corneal dystrophy and Anterior Basement membrane dystrophy). We are also trying to understand why some people develop these eye diseases and others do not. People with eye diseases as well as those without will be asked to participate in this study. Read More
Participants must be > 18 years of age and able to reliably complete study questionnaires and examination procedures.